Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Safety and the Preterm Birth Predictive Capacity of the Clinical Investigation Device 'Cervisense TPTL': an International Clinical Study

NCT06968364 is registered in ClinicalTrials.gov with Ultrasound-Innovation Medtech, S.L. as lead sponsor.

NCT NCT06968364
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06968364 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Safety and the Preterm Birth Predictive Capacity of the Clinical Investigation Device 'Cervisense TPTL': an International Clinical Study
Lead sponsor
Ultrasound-Innovation Medtech, S.L.
Phase
Not applicable
Overall status
Recruiting
Start date
May 10, 2025
Completion date
April 1, 2027
Enrollment
457 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

threatened preterm labor